219 related articles for article (PubMed ID: 23425616)
21. Conflict of interest: the elephant in your practice.
Kaliski S
Afr J Psychiatry (Johannesbg); 2013 May; 16(3):161, 163, 165. PubMed ID: 23739815
[No Abstract] [Full Text] [Related]
22. Suppressing commercial speech is not in the best interests of physicians and patients.
Chressanthis G; Khedkar P; Jain N; Poddar P; Seiders M
J Clin Hypertens (Greenwich); 2013 Mar; 15(3):219-20. PubMed ID: 23458598
[No Abstract] [Full Text] [Related]
23. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
[TBL] [Abstract][Full Text] [Related]
24. Economic grand rounds: the mismanagement of medication management.
Fleishman M
Psychiatr Serv; 2000 Apr; 51(4):457-9. PubMed ID: 10737818
[No Abstract] [Full Text] [Related]
25. [Conflicts of interest, an insidious blight on medicine].
Altisent R
Aten Primaria; 2019 Oct; 51(8):469-470. PubMed ID: 31202475
[No Abstract] [Full Text] [Related]
26. The General Medical Council and doctors' financial interests.
Adlington K; Abbasi K; Godlee F
BMJ; 2015 Jan; 350():h474. PubMed ID: 25630755
[No Abstract] [Full Text] [Related]
27. No more free lunches.
Abbasi K; Smith R
BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
[No Abstract] [Full Text] [Related]
28. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
Brown JL
Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
[No Abstract] [Full Text] [Related]
29. [Reaction to 'Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry' and to 'The importance of public-private cooperation. Comment on Vandereycken'].
Buis WM
Tijdschr Psychiatr; 2006; 48(6):500-1; author reply 501-3. PubMed ID: 16956013
[No Abstract] [Full Text] [Related]
30. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
King M; Bearman PS
Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
[TBL] [Abstract][Full Text] [Related]
31. Ethical relationships between drug companies and the medical profession.
Rosner F
Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
[No Abstract] [Full Text] [Related]
32. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Johar K
Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
[No Abstract] [Full Text] [Related]
33. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
Insel TR
JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
[No Abstract] [Full Text] [Related]
34. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
Li DG; Singer S; Mostaghimi A
JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
[TBL] [Abstract][Full Text] [Related]
35. The impact of disclosing financial ties in research and clinical care: a systematic review.
Licurse A; Barber E; Joffe S; Gross C
Arch Intern Med; 2010 Apr; 170(8):675-82. PubMed ID: 20421551
[TBL] [Abstract][Full Text] [Related]
36. The baby with the bathwater.
Buyske J
Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
[No Abstract] [Full Text] [Related]
37. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
Gostin LO
JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
[No Abstract] [Full Text] [Related]
38. [Conflicts of interest in the medical profession].
Altisent R; Delgado-Marroquín MT; Astier-Peña MP
Aten Primaria; 2019 Oct; 51(8):506-511. PubMed ID: 31248656
[TBL] [Abstract][Full Text] [Related]
39. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
Cicero MX; Curi MB; Mercurio M
Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
[No Abstract] [Full Text] [Related]
40. Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior.
Sah S
J Law Med Ethics; 2012; 40(3):482-7. PubMed ID: 23061575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
